| Heterogeneity of screening effects (Original Project: NLST-1098) |
Hormuzd Katki |
American Cancer Society |
NLST |
May 29, 2026 |
NLST-1509 |
| Behavioral effects of screening offers |
Ethan Lieber |
University of Notre Dame du Lac |
PLCO |
May 29, 2026 |
PLCO-2044 |
| Estimating the intake of moderation foods and evaluating associations with metabolomic and microbiome measures |
Kaelyn Burns |
National Cancer Institute |
IDATA |
May 11, 2026 |
IDATA-99 |
| Studies to use extended NLST follow-up data (Original Project: NLST-626) |
Hormuzd Katki |
American Cancer Society |
NLST |
May 11, 2026 |
NLST-1508 |
| Validation of the Michigan General Cancer Screening Model (M-GCSM) Using the National Lung Screening Trial Dataset |
Tanner Caverly |
Department of Veterans Affairs |
NLST |
May 11, 2026 |
NLST-1513 |
| Using Surrogate Endpoints to Improve the Design and Analysis of Randomized Screening Trials |
Yingqi Zhao |
Fred Hutchinson Cancer Center |
NLST |
May 4, 2026 |
NLST-1511 |
| Estimating the intake of moderation foods and evaluating associations with risk of cancer and mortality |
Kaelyn Burns |
National Cancer Institute |
PLCO |
May 4, 2026 |
PLCO-2045 |
| Wildfire Smoke Exposure and Cancer- and Aging-Related Outcomes in the PLCO Cohort |
Shuguang Leng |
University of New Mexico HSC |
PLCO |
Apr 28, 2026 |
PLCO-2041 |
| Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates (Original Project: PLCO-1091) |
Hormuzd Katki |
American Cancer Society |
PLCO |
Apr 28, 2026 |
PLCO-2043 |
| Deep Learning to Improve Screening of Interstitial Lung Diseases |
Asif Abdul Hameed |
Henry Ford Health |
NLST |
Apr 28, 2026 |
NLST-1505 |
| Estimating the lung cancer mortality benefit of screening within lung cancer risk strata in the National Lung Screening Trial (Original Project: 201204-0017) |
Hormuzd Katki |
American Cancer Society |
NLST |
Apr 28, 2026 |
NLST-1507 |
| Continuation of DCPP (PLCO-286/PLCO-287) |
Stephanie Smith-Warner |
Harvard TH Chan School of Public Health |
PLCO |
Apr 27, 2026 |
PLCO-2042 |
| Association between microplastic exposure and risk of never-smoking lung cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Qing Lan |
National Cancer Institute |
PLCO |
Apr 21, 2026 |
2025-0048 |
| Generalizability of the PLCO |
Sarah Robertson |
Dartmouth College |
PLCO |
Apr 20, 2026 |
PLCO-2039 |
| Treatment-Conditioned World Models for Lung Cancer Progression Prediction Using Longitudinal Low-Dose CT Imaging |
Luca Pegolotti |
Nucleo Research, Inc. |
NLST |
Apr 20, 2026 |
NLST-1502 |
| Statistical methods to detect and estimate etiologic heterogeneity in epidemiologic studies |
Anil Chaturvedi |
National Cancer Institute |
PLCO |
Apr 13, 2026 |
PLCO-2038 |
| Developing an All-cancer Risk Model |
Paul Pinsky |
National Institutes of Health |
PLCO |
Apr 13, 2026 |
PLCO-2040 |
| Integrating Early Detection of Heart Disease with Lung Cancer Powered by AI-CXR |
Morteza Naghavi |
HeartLung Technologies |
NLST |
Mar 31, 2026 |
NLST-1501 |
| AI-Enabled Opportunistic Detection of Cardiovascular Disease Risk from Chest Radiographs in the PLCO Cohort |
Morteza Naghavi |
HeartLung Technologies |
PLCO |
Mar 30, 2026 |
PLCOI-2034 |
| Integrative Genomic, Histologic, and Spatial Profiling of ClonalHematopoiesis in Lung Cancer |
Janghee Woo |
Emory University |
PLCO |
Mar 30, 2026 |
PLCOI-2024 |
